In STZ-induced diabetic Wistar rats, myricetin decreases DPP-4 activity, its expression, and diabetes-induced NLRP3 inflammasome activation, increasing circulating GLP-1 and insulin levels (30). Here, DPP4 is linked to diabetes mellitus.